Navigation Links
Peptide Therapeutics Market is Expected to Reach USD 25.4 Billion Globally in 2018: Transparency Market Research
Date:3/13/2013

ALBANY, New York, March 13, 2013 /PRNewswire/ --

According to a new market report published by Transparency Market Research (http://www.transparencymarketresearch.com) "Peptide Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018," the global peptide therapeutics market was valued at USD 14.1 billion in 2011 and is estimated to reach a market worth USD 25.4 billion in 2018 at a CAGR of 8.7% from 2012 to 2018.

Browse the full report at http://www.transparencymarketresearch.com/peptide-therapeutics-market.html

The growth of the market is driven by factors such as rising incidences of cardiovascular diseases, metabolic diseases and technological enhancement in peptide synthesis. The Asian region offers future growth prospects to the peptide industry owing to vast unmet medical needs and rising disposable income of patients.

Amongst the application market, the cancer peptide segment accounted for the largest share of approximately 21% and is expected to grow at a healthy CAGR during the forecast period. The neuropeptides application segment is anticipated to grow at a CAGR of 9.4% from 2012 to 2018 due to the rise in number of neurological disorders such as Alzheimer's and Parkinson's disease.

Related & Recently Published Reports by Transparency Market Research

http://www.transparencymarketresearch.com/radiopharmaceuticals-market.html

http://www.transparencymarketresearch.com/healthcare-cloud-computing.html

http://www.transparencymarketresearch.com/hcro-market.html

http://www.transparencymarketresearch.com/liver-diseases-therapeutics.html

http://www.transparencymarketresearch.com/bioinformatics-market.html

The parenteral route of administration of peptides accounted for the largest share of around 86% in year 2011, in terms of routes of administration; however other routes of administration like oral, pulmonary, nasal and intradermal are also being tested and are estimated to experience healthy growth rate during the forecast period.

Technological enhancement with introduction of hybrid technology along with solid phase peptide syntheses (SPPS) is expected to enhance the growth of peptide therapeutics. The hybrid technology segment which provides the best of both solid and liquid syntheses is now being adopted by major players and hence this market is expected to see the highest growth of 12.1% from 2012 to 2018.

Related & Recently Published Reports by Transparency Market Research

http://www.transparencymarketresearch.com/cinv-market.html

http://www.transparencymarketresearch.com/high-potency-active-pharmaceutical-Ingredients-market.html

http://www.transparencymarketresearch.com/global-neuromodulation-devices-market.html

http://www.transparencymarketresearch.com/preimplantation-genetic-diagnosis-market.html

http://www.transparencymarketresearch.com/cervical-cancer-diagnostic-tests-market.html

The North American peptide therapeutics market held majority of the market share of approximately 40% in 2011 owing to its developed economy. However, due to rise in cost containment and budgetary cuts in North America, emerging countries such as India, China and other Latin American countries is expected to see a healthy growth in the study period.

Some of the key market players are Eli Lilly, Roche, Amylin, Novo-Nordisk, Ipsen and others. The contract manufacturing organization (CMO) industry includes major players such as Bachem, Polypeptide Group, Lonza, Peptisyntha and others.

  • Peptide Therapeutics Market, by Applications

    Cancer

    Metabolic

    Cardiovascular

    Dermatology

    Anti-Infection

    Neurology

    Gastro Intestinal

    Renal

    Respiratory

    Pain

    Others

  • Peptide Therapeutics Market, by Route of Administration

    Parenteral

    Oral

    Pulmonary

    Mucosal

    Others

  • Peptide Therapeutics Market, by Types

    Innovative

    Generics

  • Peptide Therapeutics Market, by API Peptide

    In-House

    CMO (Contract Manufacturing Organization)

  • Peptide Therapeutics by technology

    Liquid Phase Peptide Synthesis (LPPS)

    Solid Phase Peptide Synthesis (SPPS)

    Hybrid

  • Peptide Therapeutics Market, by Geography

    North America

    Europe

    Asia

    RoW


Browse all Pharmaceutical Market Research Reports @ http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

Upcoming Reports in Pharmaceutical Market

Metabolomics Market

Medical Tourism Market

Monoclonal Antibodies Market

Cell Based Assays Market

Nutraceuticals Market

Drug Discovery Technologies Market

Sample Preparation In Genomics

Antibody Drugs Market

Osteoporosis Market

Treatments for Neurodegenerative Disorders

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact
Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Visit: http://de.transparencymarketresearch.com/
Visit: http://www.transparencymarketresearch.com/



'/>"/>
SOURCE Transparency Market Research
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Waters Unveils Industrys First Integrated LC/MS Platform for Proteins, Peptides, and Glycans Analysis at WCBP 2013
2. Small peptide ameliorates autoimmune skin blistering disease in mice
3. US Patent awarded for using Metal Peptides to Help Diminish Skin Imperfections
4. Strategic Analysis of the Collagen Peptide Market in the United States
5. Researchers shrink tumors and minimize side effects using tumor-homing peptide to deliver treatment
6. Pain Therapeutics - Drugs, Markets and Companies - 2013 Report
7. Genedata Expressionist for Mass Spectrometry Showcased at 2013 Biotherapeutics Analytical Summit
8. Array Biopharma and Global Blood Therapeutics Announce Drug Discovery Collaboration Focused on Hematology
9. Comprehensive Global Testing Solutions for Novel Hepatitis C Therapeutics, New Webinar Hosted by Xtalks
10. United Therapeutics Corporation To Announce Fourth Quarter And Annual 2012 Financial Results Before Market Open On Tuesday, February 26, 2013
11. Society for Brain Mapping and Therapeutics endorse President Obamas support for Human Brain Mapping research; nominating him for prestigious Pioneer in Healthcare Policy Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/7/2018)... ... November 07, 2018 , ... Since ... campaign to increase awareness of the adult tissue stem cell counting problem in ... November, the company is intensifying this effort with new educational publications and presentations ...
(Date:11/5/2018)... (PRWEB) , ... November 05, 2018 , ... ... and telemedicine company backed by Siemens Healthineers and several healthcare VC firms announces ... radiology solution and making a history by purchasing tokens and obtaining its first ...
(Date:11/3/2018)... ... 01, 2018 , ... Triangle Insights Group, a premier life sciences consulting firm, ... private companies in the United States, appearing on this year’s Inc. 5000 list. ... percentage revenue growth over the previous three years. , Separately, Triangle Insights was ...
(Date:10/31/2018)... ... October 30, 2018 , ... The assessment of cell health ... of experimental biology. Reproducibility of cell-based assays is one of the key points ... assay type, there are many more factors to be considered to decrease data ...
Breaking Biology Technology:
(Date:11/15/2018)... ... 2018 , ... Persivia, a provider of real-time bundled payment, ... a leading operator of over 50 hospitals nationwide, has selected Persivia’s Bundled Payment ... consists of the industry’s only end to end solution for succeeding in bundled ...
(Date:11/14/2018)... ... 14, 2018 , ... In recognition of World Diabetes Day, Diopsys is lending ... The company is reaching out to help educate patients and the healthcare community about ... vision testing for people with the disease. , The American Diabetes Association (ADA) released ...
(Date:11/13/2018)... Conn. (PRWEB) , ... November 13, 2018 , ... ... modern gum surgery alternatives with less invasive techniques, less discomfort and ... gum disease symptoms like receding, swollen and bleeding gums, and bad breath, this ...
Breaking Biology News(10 mins):